You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for PRO-BANTHINE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PRO-BANTHINE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free P8891_SIGMA ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-003-666-273 ⤷  Get Started Free
Hangzhou APIChem Technology ⤷  Get Started Free AC-13428 ⤷  Get Started Free
Amadis Chemical ⤷  Get Started Free A828073 ⤷  Get Started Free
AKos Consulting & Solutions ⤷  Get Started Free AKOS015895527 ⤷  Get Started Free
Finetech Industry Limited ⤷  Get Started Free FT-0603218 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for: PRO-BANTHINE

Last updated: July 28, 2025


Introduction

Pro-Banthine, known chemically as propantheline bromide, is a synthetic anticholinergic drug primarily utilized to treat gastrointestinal disorders such as peptic ulcers, irritable bowel syndrome, and excessive salivation. Its therapeutic efficacy hinges on the quality and supply of high-grade propantheline bromide API. As the pharmaceutical industry emphasizes supply chain stability, regulatory compliance, and cost-effectiveness, understanding global API sources for Pro-Banthine is crucial for stakeholders including manufacturers, distributors, and regulatory authorities.


Overview of Propantheline Bromide as an API

Propantheline bromide, a quaternary ammonium compound, exerts its effects by antagonizing muscarinic cholinergic receptors, reducing gastrointestinal motility, and secretions. Its synthesis involves multiple complex chemical processes that demand stringent quality standards to meet pharmacopoeial specifications such as USP, EP, or JP.

The production of this API demands precision and adherence to Good Manufacturing Practice (GMP), influencing sourcing strategies globally. Suppliers must comply with regional regulatory frameworks, ensure consistent purity levels, and maintain scalable manufacturing capacities.


Global API Manufacturing Regions for Pro-Banthine

1. India

India constitutes a dominant player in the global API manufacturing landscape due to its extensive pharmaceutical infrastructure, cost advantages, and robust regulatory framework through agencies like the Central Drugs Standard Control Organization (CDSCO).

Key Manufacturers:

  • Sun Pharmaceutical Industries Ltd.
    Known for extensive API portfolios, including gastrointestinal agents, Sun Pharma supplies propantheline bromide APIs to both domestic and international markets.

  • Divi's Laboratories.
    Specializes in complex APIs and intermediates, offering high-quality propantheline bromide API with compliance to stringent quality standards.

Strengths:

  • Competitive pricing
  • Mature supply chain networks
  • Capacity for large-scale production

Challenges:

  • Regulatory updates requiring continuous compliance
  • Quality assurance variability; requires diligent vendor auditing

2. China

China's API industry rapidly expanded over the last two decades, driven by government incentives and rising domestic demand. Major Chinese API manufacturers produce propantheline bromide within broader gastrointestinal API portfolios.

Leading Companies:

  • Huiyuan Biotechnology Co., Ltd.
    Engaged in gastrointestinal API synthesis, with export experience in the international market.

  • North China Pharmaceutical Group Corporation (NCPC).
    Offers a range of APIs, including those utilized for anticholinergic medications.

Strengths:

  • Cost-effective manufacturing
  • Expanding capacity and infrastructure

Challenges:

  • Variability in quality assurance and regulatory transparency
  • Increasing scrutiny from international authorities (EMA, FDA)

3. European Union and USA

The top-tier markets for high-quality APIs often source from regional manufacturers with extensive GMP compliance.

European API Suppliers:

  • Madaus GmbH (Germany)
    Produces pharmaceutical ingredients with certification standards exceeding regional benchmarks.

  • Almac Group (UK)
    Offers custom synthesis and supply of specialty APIs, including bulk propantheline bromide for clinical trials and limited commercial distribution.

US API Manufacturers:

  • Bachem Holding AG (Switzerland, with offices in US)
    Known for high purity and custom manufacturing, serving premium markets.

Strengths:

  • Strict regulatory adherence, ensuring high-quality APIs
  • Reliable supply chains and documentation

Challenges:

  • Higher production costs
  • Limited capacity for large-scale low-cost manufacturing

Regulatory Considerations and Supply Chain Implications

Sourcing APIs for Pro-Banthine necessitates compliance with international regulations such as the FDA’s Current Good Manufacturing Practice (cGMP), European Pharmacopoeia standards, and other regional quality benchmarks. Validated documentation, stability data, and bioequivalence testing underpin the supply chain.

Supply chain disruptions, geopolitical factors, and regional trade policies significantly influence procurement strategies. Suppliers from India and China dominate due to cost efficiencies but demand rigorous quality audits and ongoing regulatory oversight.


Emerging Trends in API Sourcing for Pro-Banthine

  • Collaborative Manufacturing: Pharmaceutical companies increasingly engage in joint ventures or licensing agreements with regional suppliers to ensure quality and supply continuity.

  • Crucial Role of API Intermediates: The synthesis route for propantheline bromide involves intermediates, with some manufacturers specializing in intermediate production, thus diversifying source options.

  • Sustainability & Green Chemistry: Regulatory movements emphasize environmentally friendly manufacturing, influencing sourcing decisions toward eco-conscious API producers.

  • Digital Supply Chain Monitoring: Adoption of digital platforms enhances traceability and quality assurance across the supply chain, mitigating risks associated with API sourcing.


Key Criteria for Selecting API Suppliers

  • Regulatory Compliance: Certification under GMP, ISO standards, and regional regulatory approvals.
  • Quality Assurance: Consistency in API purity, potency, and batch-to-batch reproducibility.
  • Manufacturing Capacity: Ability to meet current and projected demand.
  • Cost & Lead Time: Competitive pricing balanced with reliable delivery schedules.
  • Traceability & Documentation: Complete CMDO (Chemistry, Manufacturing, and Control documentation).

Conclusion

The global market for bulk propantheline bromide API is predominantly driven by suppliers in India, China, and regional Western markets. Indian manufacturers provide cost-effective, scalable options, while Chinese and Western suppliers emphasize regulatory compliance and quality standards. Strategic sourcing for Pro-Banthine API hinges on balancing cost, quality, regulatory adherence, and supply chain robustness, especially amid evolving geopolitical and regulatory landscapes.


Key Takeaways

  • India and China dominate the global propantheline bromide API supply, offering scalable and cost-efficient options.
  • European and US suppliers focus on quality assurance, with certifications aligning with stringent regulatory standards.
  • Supply chain risk mitigation involves rigorous supplier validation, diversified sourcing, and continuous regulatory compliance monitoring.
  • Emerging trends emphasize sustainability and digital transparency in API manufacturing.
  • Strategic vendor selection should weigh regulatory approval, quality control, capacity, and delivery reliability.

FAQs

1. What are the primary factors influencing API sourcing decisions for Pro-Banthine?
Key considerations include regulatory compliance, API purity and potency, manufacturing capacity, cost, and supply chain reliability.

2. Is India a reliable source for bulk propantheline bromide API?
Yes. Indian manufacturers like Sun Pharma and Divi’s Laboratories are renowned for GMP-compliant production, quality consistency, and competitive pricing.

3. How does regional regulation affect API quality and sourcing?
Regulatory frameworks like the FDA and EMA enforce strict GMP standards, impacting supplier qualification, quality assurance, and import/export processes.

4. Are Chinese API suppliers suitable for high-quality Pro-Banthine API?
Many Chinese suppliers can produce high-quality APIs; however, due diligence regarding GMP certification, quality control, and regulatory transparency is essential.

5. What future trends could impact the API supply landscape for Pro-Banthine?
Advancements in green chemistry, digital supply chain management, and geopolitical shifts may influence sourcing options and criteria in the future.


Sources

[1] U.S. Pharmacopeia (USP). Propantheline Bromide Monograph.
[2] European Pharmacopoeia (EP). Propantheline Bromide Monograph.
[3] Indian Pharmacopoeia Commission. Guidelines for API manufacturing.
[4] Global API Market Reports. (2022). Marketwatch.
[5] Regulatory Agency Websites—FDA, EMA, CDSCO.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.